These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 30905577)

  • 1. Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases.
    Sahu I; Haque AKMA; Weidensee B; Weinmann P; Kormann MSD
    Mol Ther; 2019 Apr; 27(4):803-823. PubMed ID: 30905577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases.
    Trepotec Z; Lichtenegger E; Plank C; Aneja MK; Rudolph C
    Mol Ther; 2019 Apr; 27(4):794-802. PubMed ID: 30655211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.
    Kowalski PS; Rudra A; Miao L; Anderson DG
    Mol Ther; 2019 Apr; 27(4):710-728. PubMed ID: 30846391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.
    Maruggi G; Zhang C; Li J; Ulmer JB; Yu D
    Mol Ther; 2019 Apr; 27(4):757-772. PubMed ID: 30803823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA-based therapeutics--developing a new class of drugs.
    Sahin U; Karikó K; Türeci Ö
    Nat Rev Drug Discov; 2014 Oct; 13(10):759-80. PubMed ID: 25233993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic mRNA Delivery to the Lungs by Functional Polyester-based Carriers.
    Yan Y; Xiong H; Zhang X; Cheng Q; Siegwart DJ
    Biomacromolecules; 2017 Dec; 18(12):4307-4315. PubMed ID: 29141136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration.
    Johler SM; Rejman J; Guan S; Rosenecker J
    PLoS One; 2015; 10(9):e0137504. PubMed ID: 26352268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the Inflammatory Pathway Enhances Both the in Vitro and in Vivo Transfection Activity of Exogenous in Vitro-Transcribed mRNAs Delivered by Lipid Nanoparticles.
    Ohto T; Konishi M; Tanaka H; Onomoto K; Yoneyama M; Nakai Y; Tange K; Yoshioka H; Akita H
    Biol Pharm Bull; 2019; 42(2):299-302. PubMed ID: 30713260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.
    Guan S; Rosenecker J
    Gene Ther; 2017 Mar; 24(3):133-143. PubMed ID: 28094775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Materials for non-viral intracellular delivery of messenger RNA therapeutics.
    Kauffman KJ; Webber MJ; Anderson DG
    J Control Release; 2016 Oct; 240():227-234. PubMed ID: 26718856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium.
    Patel AK; Kaczmarek JC; Bose S; Kauffman KJ; Mir F; Heartlein MW; DeRosa F; Langer R; Anderson DG
    Adv Mater; 2019 Feb; 31(8):e1805116. PubMed ID: 30609147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges.
    Steinle H; Behring A; Schlensak C; Wendel HP; Avci-Adali M
    Stem Cells; 2017 Jan; 35(1):68-79. PubMed ID: 27250673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope.
    Aslan C; Kiaie SH; Zolbanin NM; Lotfinejad P; Ramezani R; Kashanchi F; Jafari R
    BMC Biotechnol; 2021 Mar; 21(1):20. PubMed ID: 33691652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic mRNA delivery to leukocytes.
    Granot-Matok Y; Kon E; Dammes N; Mechtinger G; Peer D
    J Control Release; 2019 Jul; 305():165-175. PubMed ID: 31121277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA vaccine delivery using lipid nanoparticles.
    Reichmuth AM; Oberli MA; Jaklenec A; Langer R; Blankschtein D
    Ther Deliv; 2016; 7(5):319-34. PubMed ID: 27075952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-specific drug targeting in the lung.
    Abed S; Turner R; Serniuck N; Tat V; Naiel S; Hayat A; Mekhael O; Vierhout M; Ask K; Rullo AF
    Biochem Pharmacol; 2021 Aug; 190():114577. PubMed ID: 33887259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA: A Novel Avenue to Antibody Therapy?
    Schlake T; Thran M; Fiedler K; Heidenreich R; Petsch B; Fotin-Mleczek M
    Mol Ther; 2019 Apr; 27(4):773-784. PubMed ID: 30885573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-based pulmonary delivery system: a review and future considerations of formulation strategies and limitations.
    Ngan CL; Asmawi AA
    Drug Deliv Transl Res; 2018 Oct; 8(5):1527-1544. PubMed ID: 29881970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of oligonucleotides with lipid nanoparticles.
    Wang Y; Miao L; Satterlee A; Huang L
    Adv Drug Deliv Rev; 2015 Jun; 87():68-80. PubMed ID: 25733311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid Nanoparticle Systems for Enabling Gene Therapies.
    Cullis PR; Hope MJ
    Mol Ther; 2017 Jul; 25(7):1467-1475. PubMed ID: 28412170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.